Serum long chain omega-3 fatty acids and depression among adults in the United States: An analysis of NHANES 2011–2012
Abstract
Abstract Background Few studies have examined biomarkers of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) with depression, that are less prone to error than self-reported intake. We aimed to determine associations between serum EPA, DHA and the sum of long chain (LC) omega-3 fatty acids with depression in the National Health and Nutrition Examination Survey (NHANES) 2011–2012 cycle. Methods Fatty acids were expressed as a % of total fatty acids. Depression was assessed by the Patient Health Questionnaire (PHQ)-9 and categorized as minimal (score 0–4, reference), mild (5–9), moderate (10–14), and moderately severe to severe depression (15–27). The impact of depressive symptoms was also assessed. Associations were estimated by regression with adjustment for sociodemographic covariates. Results Among 1186 adults, 77.9% reported minimal depressive symptoms, while 14.3%, 5.06% and 2.75% of participants had mild, moderate and moderately severe to severe depression. Higher serum EPA, DHA and LC omega-3 fatty acids were associated with lower relative risk (RR) of moderately severe to severe depression. For example, EPA: RR=0.30, SE 0.11, p = 0.005. Participants with higher serum EPA, were less likely to report very or extreme difficulty with daily life tasks due to depressive symptoms (RR=0.39, SE 0.17, p = 0.05). Limitations The temporal nature of relationships cannot be determined due to the cross-sectional design. Conclusion Higher serum omega-3 fatty acids were…
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.